| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,651 | 5,552 | 692 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 2,651 | 5,552 | 692 | | | Operating Expenses | | Research Development | 20,663 | 21,789 | 28,644 | | Selling General and Administrative | 19,832 | 17,041 | 21,288 | | Non Recurring |
-
|
-
| 1,374 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (37,844) | (33,278) | (50,613) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,226 | 1,468 | 2,021 | | Earnings Before Interest And Taxes | (23,618) | (31,810) | (48,592) | | Interest Expense | 5,080 | 4,985 | 3,289 | | Income Before Tax | (28,698) | (36,795) | (51,881) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (28,698) | (36,795) | (51,881) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (28,698) | (36,795) | (51,881) | | Preferred Stock And Other Adjustments | (791) | (791) | (791) | | | Net Income Applicable To Common Shares | ($29,488) | ($37,586) | ($52,671) |
|
0.12% Nasdaq 
0.16%
Income Statement
